The Long Shot: The Inside Story of the Race to Vaccinate Britain
Description:
On 3 April 2020, Kate Bingham was told that the likelihood of any Covid-19 vaccine working was 15% at best. But on 8 December 2020, the first NHS patient received a vaccine. Now nearly every adult in Britain has had a jab, lockdowns have ended and we can finally live with Covid. What lies behind this staggering success story?
From a cottage miles away from Westminster, Bingham juggled vaccine suppliers, Whitehall, the media circus - and her daughter's exams. Political manoeuvring, miscommunications and administrative meddling nearly jeopardised the project. But perseverance paid off.
Catapulted into a national crisis, Bingham's eclectic team secured the first vaccine doses administered in the West and saved thousands of lives in the UK as new variants struck. This is an unmissable insider view into how the Vaccine Taskforce beat the odds and delivered the scientific miracle we all waited for.
Best prices to buy, sell, or rent ISBN 9780861545643
Frequently Asked Questions about The Long Shot: The Inside Story of the Race to Vaccinate Britain
The price for the book starts from $6.31 on Amazon and is available from 41 sellers at the moment.
At BookScouter, the prices for the book start at $1.01. Feel free to explore the offers for the book in used or new condition from various booksellers, aggregated on our website.
If you’re interested in selling back the The Long Shot: The Inside Story of the Race to Vaccinate Britain book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the The Long Shot: The Inside Story of the Race to Vaccinate Britain book, the best buyback offer comes from and is $ for the book in good condition.
The The Long Shot: The Inside Story of the Race to Vaccinate Britain book is in very low demand now as the rank for the book is 3,202,468 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.